1 / 13

Company-initiated clinical trials in Denmark in 2013

Company-initiated clinical trials in Denmark in 2013. Based on a survey among members of DANSK BIOTEK (Danish Association of Biotechnology Industries and Lif (Danish Association of the Pharmaceutical Industry). Trend in the number of trials for Lif companies.

michelle-briggs
Télécharger la présentation

Company-initiated clinical trials in Denmark in 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Company-initiated clinical trials in Denmark in 2013 Based on a survey among members of DANSK BIOTEK (Danish Association of Biotechnology Industries and Lif (Danish Association of the Pharmaceutical Industry).

  2. Trend in the number of trials for Lif companies Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013

  3. Stagnation in the number of company-initiated clinical trials in Denmark • DANSK BIOTEK and Lif's members carried out a total of 296 clinical trials in 2013 – 99 of which were new trials. • The stabilisation noted in 2012 thus continued into 2013.

  4. Trials conducted under the aegis of CROs • 73 trials were conducted under the aegis of external CROs* in 2013. • After a marked increase between 2011 and 2012 (50 to 82), numbers of this type of trial have now again dropped back slightly. Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013 *Contract Research Organisations

  5. Drop in numbers of trial subjects • In 2013, a total of 16,249 individuals participated in clinical trials in Denmark. • This was significantly down on the previous three years when the number of trial subjects was more stable. • The drop was also due to an increase in the proportion of early stage trials in which not so many subjects usually participate. • Early stage trials are increasing, especially for cancer. Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013

  6. Trend in numbers of trial subjects * * * Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013 * This year’s counting does not include patients participating in clinical trials taking place under the auspices of external CROs.

  7. Number of personnel engaged in clinical research • 1,854 full-time internal company personnel were engaged in clinical research in 2013, slightly up on previous years. • 198 of these were engaged in clinical research carried out in Denmark. This was down on the 225 reported in 2012. • A further 55 full-time personnel were engaged in clinical research in Denmark via external CROs. This was in line with 2012. 1,854 personnel. Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013

  8. Expenditure on clinical trials • External expenditure by members of DANSK BIOTEK and Lif were in total DKK 212.4m in 2013 for research primarily done by the national health service. • This was markedly down on 2012.The stability noted since 2010 has now been replaced by a decline. Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013

  9. Distribution of expenditure on clinical research in 2013 • External spending on clinical trials managed and conducted by Lif and DANSK BIOTEK’s member companies totalled DKK 157.6m. • Added to this external expenditure via CROs on fees and contributions to hospitals/university institutions, research foundations, investigators, lab reports, etc., totalled DKK 21.9m. • DKK 32.9m was spent on investigator-initiated trials. • Total external spending amounted to DKK 212.4m Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013

  10. Clinical studies on children: General increase since 2009

  11. Number of non-intervention trials is stable Source: Lif and DANSK BIOTEK’s survey of clinical research activities in Denmark in 2013

  12. Find all the reports at Lif.dk

  13. The Infographic can be downloaded from lif.dk (only in Danish)

More Related